Article

Medicare Improvement Project Linked to Health Law Takes Next Step

Federal health officials are moving forward with a plan to reward healthcare providers that improve services for Medicare patients.

The four-year project will be administered by the Medicare agency's Innovation Center, a creation of the 2010 healthcare law that seeks to reduce costs and improve healthcare delivery.

Read the full story: http://tinyurl.com/bpf2fjz

Source: The Hill

Related Videos
James Chambers, PhD
Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah.
Screenshot of an interview with Ruben Mesa, MD
dr carol regueiro
dr carol regueiro
Screenshot of Adam Colborn, JD during an interview
Ruben Mesa, MD
dr carol regueiro
Screenshot of Susan Wescott, RPh, MBA
Related Content
Elevating Value in Cancer Care With Innovations, Accessibility, Equity
November 21st 2024

Elevating Value in Cancer Care With Innovations, Accessibility, Equity

Cameron Santoro
Coverage from the IVBM Regional event in Denver, Colorado.
Managed Care Cast
November 21st 2024

Frameworks for Advancing Health Equity: Wellness Way

Giuliana Grossi
The Wellness Way facility was designed to improve access to comprehensive outpatient care and address social determinants of health for a diverse patient population.
Cost of health care | Image Credit: Scott Hales - stock.adobe.com
November 21st 2024

Despite Record ACA Enrollment, Report Reveals Underinsured Americans Are in Crisis

Giuliana Grossi
Despite significant progress in expanding health insurance coverage since the Affordable Care Act (ACA) was enacted, millions of Americans still face critical gaps in access to and affordability of health care.
managed care cast logo
October 24th 2024

Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions

Brooke McCormick
On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Entresto packaging | Image credit: Novartis
November 18th 2024

Cardiomyopathy Risk Plummets When Sacubitril/Valsartan Taken With Chemo

Mary Caffrey
The SARAH trial was limited to high-risk patients, which the lead investigator said prevented unnecessary exposure to adverse events in patients less at risk of cardiomyopathy.
Milton Packer, MD | Image credit: Baylor, Scott, and White
November 16th 2024

For Obesity and HFpEF, Tirzepatide Cuts Risk of CV Death or Worsening HF by 38%

Mary Caffrey
Payers and employers have tightened access to the glucagon-like peptide 1 receptor agonist class once these therapies became more commonly prescribed for obesity.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo